UBS Group
MDXG icon

UBS Group’s MiMedx Group MDXG Stock Holding History

UBS Group’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65,000
Closed -$568K – 7870
2016
Q1 		$568K Buy
+65,000
New +$540K ﹤0.01% 3680
2015
Q1 		– Sell
-500
Closed -$6K – 9112
2014
Q4 		$6K Buy
+500
New +$4.94K ﹤0.01% 8837

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group's MDXG Position: Q2 2026 in Review

UBS Group reduced its MiMedx Group (MDXG) stake by 65% in Q2 2026, selling an estimated $1.59M and leaving 236,033 shares worth $909K. The position accounts for ﹤0.01% of the portfolio, ranked #5818.

UBS Group first reported a position in MDXG in Q4 2014 and has held it in 39 quarters since. The position peaked at $5.29M in Q1 2018. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • UBS Group held 236,033 shares of MiMedx Group worth $909K as of Q2 2026.
  • UBS Group sold 436,969 MiMedx Group shares in Q2 2026, an estimated $1.59M.
  • MiMedx Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5818 holding.
  • UBS Group first reported a position in MiMedx Group in Q4 2014 and has held it in 39 quarters since.
  • UBS Group's MiMedx Group position peaked at $5.29M in Q1 2018.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.